High-Dose Methotrexate and Cytarabine-Based Multi-Agent Chemotherapy (Modified Bonn Protocol) for Systemic Lymphoma with CNS Involvement | Semantic Scholar
High-dose methotrexate is effective for prevention of isolated CNS relapse in diffuse large B cell lymphoma | Blood Cancer Journal
CNS Prophylaxis by Treatment Protocol CNS Prophylaxis | Download Table
Primary Central Nervous System Lymphoma in Elderly Patients: Management and Perspectives
Brain MRI scans for patient #5, immediately before and 20 months after... | Download Scientific Diagram
Frontiers | Non-Myeloablative Chemotherapy as Consolidation Strategy After High-Dose Methotrexate-Based Chemoimmunotherapy in Patients With Primary CNS Lymphoma: A Retrospective Single Center Study in China
Evolving Treatments for Primary Central Nervous System Lymphoma | American Society of Clinical Oncology Educational Book
Retrospective analysis of 119 cases of pediatric acute promyelocytic leukemia: Comparisons of four treatment regimes
![PDF] High-dose cytarabine plus high-dose methotrexate versus high-dose methotrexate alone in patients with primary CNS lymphoma: a randomised phase 2 trial | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/4416910c73a7fb4f74309dd046ab9aa41c7dd7b5/6-Figure1-1.png "PDF] High-dose cytarabine plus high-dose methotrexate versus high-dose methotrexate alone in patients with primary CNS lymphoma: a randomised phase 2 trial | Semantic Scholar")
PDF] High-dose cytarabine plus high-dose methotrexate versus high-dose methotrexate alone in patients with primary CNS lymphoma: a randomised phase 2 trial | Semantic Scholar
Cancers | Free Full-Text | A Systematic Review of High-Dose Methotrexate for Adults with Primary Central Nervous System Lymphoma
Leading prognostic relevance of the BCR-ABL translocation in adult acute B-lineage lymphoblastic leukemia: a prospective study of the German Multicenter Trial Group and confirmed polymerase chain reaction analysis - ScienceDirect
R-CHOP intensification with mid-cycle methotrexate and consolidating AraC/TT with BCNU/aHSCT in primary aggressive lymphoma with CNS involvement | SpringerLink
Prophylaxis with intrathecal or high-dose methotrexate in diffuse large B-cell lymphoma and high risk of CNS relapse | Blood Cancer Journal
High-dose methotrexate-based regimens and post-remission consolidation for treatment of newly diagnosed primary CNS lymphoma: meta-analysis of clinical trials | Scientific Reports
Current and emerging therapies for primary central nervous system lymphoma | Biomarker Research | Full Text
Overview of regimens and cumulative doses of ara-C and anthracyclines... | Download Scientific Diagram
Cancers | Free Full-Text | Primary Central Nervous System Lymphoma in Elderly Patients: Management and Perspectives
![Hong Kong Journal of Paediatrics [HK J Paediatr (New Series) 2022;27:249-258]](https://www.hkjpaed.org/figure/2022;27;249-258-fig1.jpg "Hong Kong Journal of Paediatrics [HK J Paediatr (New Series) 2022;27:249-258]")
Hong Kong Journal of Paediatrics [HK J Paediatr (New Series) 2022;27:249-258]
Figure 1 from Primary central nervous system lymphoma treated with high-dose methotrexate, high-dose busulfan/thiotepa, autologous stem-cell transplantation and response-adapted whole-brain radiotherapy: results of the multicenter Ostdeutsche ...
![PDF] Immunochemotherapy with Intensive Consolidation for Primary CNS Lymphoma: A Pilot Study and Prognostic Assessment by Diffusion-Weighted MRI | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/f825b000777a15ee38571331fdd5db403cb72a63/3-Table1-1.png "PDF] Immunochemotherapy with Intensive Consolidation for Primary CNS Lymphoma: A Pilot Study and Prognostic Assessment by Diffusion-Weighted MRI | Semantic Scholar")
PDF] Immunochemotherapy with Intensive Consolidation for Primary CNS Lymphoma: A Pilot Study and Prognostic Assessment by Diffusion-Weighted MRI | Semantic Scholar
High-dose cytarabine plus high-dose methotrexate versus high-dose methotrexate alone in patients with primary CNS lymphoma: a randomised phase 2 trial - The Lancet
Frontiers | High-Dose Methotrexate-Induced Idiopathic Intracranial Hypertension in Infant Acute Lymphoblastic Leukemia
High-dose methotrexate-based regimens and post-remission consolidation for treatment of newly diagnosed primary CNS lymphoma: meta-analysis of clinical trials | Scientific Reports
Frontiers | Non-Myeloablative Chemotherapy as Consolidation Strategy After High-Dose Methotrexate-Based Chemoimmunotherapy in Patients With Primary CNS Lymphoma: A Retrospective Single Center Study in China
![PDF] Rituximab, methotrexate, procarbazine, and vincristine followed by consolidation reduced-dose whole-brain radiotherapy and cytarabine in newly diagnosed primary CNS lymphoma: final results and long-term outcome. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/33c3fd8f11bde6998f8b7408bfca1dc11e3fce4d/3-Figure1-1.png "PDF] Rituximab, methotrexate, procarbazine, and vincristine followed by consolidation reduced-dose whole-brain radiotherapy and cytarabine in newly diagnosed primary CNS lymphoma: final results and long-term outcome. | Semantic Scholar")
PDF] Rituximab, methotrexate, procarbazine, and vincristine followed by consolidation reduced-dose whole-brain radiotherapy and cytarabine in newly diagnosed primary CNS lymphoma: final results and long-term outcome. | Semantic Scholar
Cancers | Free Full-Text | High-Dose Chemotherapy with Autologous Hematopoietic Stem Cell Transplantation in Relapsed or Refractory Primary CNS Lymphoma: A Retrospective Monocentric Analysis of Long-Term Outcome, Prognostic Factors, and Toxicity
HDMTX-based induction therapy followed by consolidation with conventional systemic chemotherapy and intraventricular therapy (modified Bonn protocol) in primary CNS lymphoma: a monocentric retrospective analysis | Neurological Research and Practice ...
Comparison of leukemia prognostic features among arm C patients with... | Download Table
